Memgen, Inc.
Memgen's Vision: Develop Life-Saving Cancer Immunotherapies
7 employees · est. 2004 · Houston, United States
Surface Oncology Inc.
#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021
14 employees · est. 2014 · Cambridge, United States
Memgen, Inc. is the older company (2004 vs 2014); Surface Oncology Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Memgen, Inc. | Surface Oncology Inc. |
|---|---|---|
| Founded | ||
| Founded | 2004 older | 2014 |
| Headquarters | ||
| Headquarters | Houston, United States | Cambridge, United States |
| Employees | ||
| Employees | 7 | 14 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $88.90M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cancer Immunotherapy, Viral Immunotherapies, Oncolytic Virus, Vaccine Development, Adjuvant Therapy, Clinical Trials, Immune System Modulation, Antigen-Specific Immune Responses, Infectious Disease Prevention, COVID-19 Vaccines, Immune Response Stimulation, Cytokine Therapy, Collaborative Research, Advanced Cancer Treatment | Immuno-oncology, Cancer Therapy, TME Biology, Immune System, Antibody Candidates, Cancer Research, Novel Immunotherapy Targets, Tumor Microenvironment, Immune Evasion, Biological Pathways, Clinical-stage, Cancer Treatments, Scientific Founders, Biological Research |
| Website | ||
| Website | memgenbio.com | surfaceoncology.com |
About Memgen, Inc.
Memgen, Inc. is a clinical-stage biotech company with the vision of developing life-saving cancer immunotherapies. They focus on harnessing the power of the immune system to potentially cure cancer and protect people from infectious diseases. Memgen's pipeline products utilize its proprietary CD40L...
About Surface Oncology Inc.
Surface Oncology Inc. is a clinical-stage immuno-oncology company that was founded in 2014. The company is headquartered in the United States and has recently received a significant $28.90MPost-IPO Equity investment on 20 May 2020 from BVF Partners, EcoR1 Capital, Venrock Healthcare Capital Partners...
We will tell you when either one moves
BounceWatch watches Memgen, Inc. and Surface Oncology Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Memgen, Inc. and Surface Oncology Inc. — by email.
Frequently Asked Questions
Compare Memgen, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Memgen, Inc. on 28 Oct 2024, and Surface Oncology Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.